Fresenius Kabi USA, LLC FDA Inspection Record

FEI 3001833549 · Inspections, Form 483s, warning letters and import refusals

Fresenius Kabi USA, LLC is an FDA-registered facility (FEI 3001833549) located in Grand Island, NY, US. Registered operations: ANALYSIS; MANUFACTURE. RegDataLab tracks 14 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Oct 13, 2023: Voluntary Action Indicated (VAI)
Inspections on record
14 (2 OAI, 9 VAI, 3 NAI)
Last OAI inspection
Jan 11, 2013
Warning letters
1 listed by FDA for this FEI, latest Feb 22, 2012
Form 483 and inspection documents
2 in FDA's reading room
Recalls as the recalling firm
3, latest May 22, 2019

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 14 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Oct 13, 2023Voluntary Action Indicated (VAI)Procedures for sterile drug products (21 CFR 211.113(b))
Investigations of discrepancies, failures (21 CFR 211.192)
Aug 30, 2023Voluntary Action Indicated (VAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Aug 12, 2019Voluntary Action Indicated (VAI)No citations listed
Mar 30, 2017No Action Indicated (NAI)No citations listed
Feb 1, 2017Voluntary Action Indicated (VAI)No citations listed
Feb 4, 2016Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Training , Education , Experience overall (21 CFR 211.25(a))
Quality control unit review of records (21 CFR 211.192)
Investigations of discrepancies, failures (21 CFR 211.192)
and 1 more
Oct 24, 2014Voluntary Action Indicated (VAI)Buildings of Suitable Size, Construction, Location (21 CFR 211.42(a))
Representative Samples Criteria (21 CFR 211.84(b))
Investigations of discrepancies, failures (21 CFR 211.192)
Jan 11, 2013Official Action Indicated (OAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Written procedures not established/followed (21 CFR 211.67(b))
Procedures for sterile drug products (21 CFR 211.113(b))
Investigations of discrepancies, failures (21 CFR 211.192)
and 4 more
Aug 29, 2011Voluntary Action Indicated (VAI)No citations listed
Jul 8, 2011Official Action Indicated (OAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
May 22, 2019Class IIID-1386-2019Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC…
Failed Impurities/Degradation Specifications.
Nov 15, 2018Class ID-0298-2019SODIUM CHLORIDE INJECTION, USP, 0.9%, 10 mL Single Dose Vial, packaged in a 25-unit tray… and 1 more product
Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product…
Jan 22, 2014Class IID-1148-2014Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV…
Subpotent; 18 month time point

Form 483s and inspection documents

  • 483 on FDA.gov
    FDA listing date May 14, 2026, which is not always the inspection or issue date. Published by FDA Oct 20, 2026.
  • 483 on FDA.gov
    Inspection Jun 13, 2011 to Jul 8, 2011 (dates printed on the document). FDA listing date Jul 10, 2015. Published by FDA Jan 18, 2024.

FDA record score

13 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

14 records behind this number
RecordDatePoints x age weightAdds
Class I recall D-0298-2019, this FEI as the recalling firmNov 15, 201815 x 0.253.8
Inspection classified VAIOct 13, 20236 x 0.63.6
Inspection classified VAIAug 30, 20236 x 0.63.6
Inspection classified VAIAug 12, 20196 x 0.251.5
Inspection classified VAIFeb 1, 2017Only the 3 most recent VAI inspections add points0
Inspection classified VAIFeb 4, 201610 years or older, so it adds no points0
Inspection classified VAIOct 24, 201410 years or older, so it adds no points0
Class II recall D-1148-2014, this FEI as the recalling firmJan 22, 201410 years or older, so it adds no points0
Inspection classified OAIJan 11, 201310 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsFeb 22, 201210 years or older, so it adds no points0
Inspection classified VAIAug 29, 201110 years or older, so it adds no points0
Inspection classified OAIJul 8, 201110 years or older, so it adds no points0
Inspection classified VAIJan 13, 201010 years or older, so it adds no points0
Inspection classified VAISep 17, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing Fresenius Kabi USA, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Fresenius Kabi USA, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Fresenius Kabi USA, LLC
Location
Grand Island, NY (US)
Registration Expires
Dec 31, 2027
Operations
ANALYSIS; MANUFACTURE
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.